Literature DB >> 28116455

[Dermatophyte : Current situation].

P Mayser1.   

Abstract

Currently, a mycid is defined as hyperergic reaction that develops from a remote localized infection and in which no fungus is detectable. Criteria for a mycid caused by a dermatophyte (dermatophytid) are (1) proven dermatophytosis elsewhere, (2) no evidence for fungal elements in the lesions of the -id reaction, (3) initially often worsening of the lesions under therapy with highly potent systemic antimycotics, and (4) clearing after the dermatophytosis has been treated sufficiently. The most common dermatophytid is a symmetrical dyshidrotic mycid of the hands in connection with an often highly inflammatory mycotic infection of the feet especially by Trichophyton mentagrophytes. In addition to lichen trichophyticus, dermatophytids associated with tinea capitis may show high clinical variability. They often occur under systemic antimycotic therapy and have to be differentiated from drug reactions. In addition to systemic antimycotic therapy and, if necessary, a short-term application of oral glucocorticoidsteroids, a topical combination of an antifungal and a glucocorticosteroid is effective. It leads to an immediate reduction of inflammation and pruritus, especially if initiation of systemic antifungal therapy has resulted in a flare-up reaction (overtreatment phenomenon).

Entities:  

Keywords:  Antifungals; Lichen trichophyticus; Mycid; Overtreatment phenomenon; Steroids

Mesh:

Substances:

Year:  2017        PMID: 28116455     DOI: 10.1007/s00105-017-3933-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  32 in total

1.  Tinea capitis: an epidemiologic, therapeutic and laboratory investigation of 6,390 cases.

Authors:  A DOSTROVSKY; G KALLNER; F RAUBITSCHEK; F SAGHER
Journal:  J Invest Dermatol       Date:  1955-03       Impact factor: 8.551

Review 2.  Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management.

Authors:  Macit Ilkit; Murat Durdu; Mehmet Karakaş
Journal:  Crit Rev Microbiol       Date:  2012-02-03       Impact factor: 7.624

Review 3.  Immunology of dermatophytes and dermatophytosis.

Authors:  S F Grappel; C T Bishop; F Blank
Journal:  Bacteriol Rev       Date:  1974-06

Review 4.  Childhood erythema nodosum associated with kerion celsi: a case report and review of literature.

Authors:  Ines Zaraa; Sondes Trojjet; Nadia El Guellali; Dalenda El Euch; Ines Chelly; Mourad Mokni; Mohamed Zitouna; Amel Ben Osman
Journal:  Pediatr Dermatol       Date:  2011-06-22       Impact factor: 1.588

5.  Detection of xanthomegnin in epidermal materials infected with Trichophyton rubrum.

Authors:  A K Gupta; I Ahmad; I Borst; R C Summerbell
Journal:  J Invest Dermatol       Date:  2000-11       Impact factor: 8.551

Review 6.  Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.

Authors:  Arjen F Nikkels; Nazli Nikkels-Tassoudji; Gérald E Piérard
Journal:  Am J Clin Dermatol       Date:  2006       Impact factor: 7.403

7.  Are Dermatophytid Reactions in Patients with Kerion Celsi Much More Common Than Previously Thought? A Prospective Study.

Authors:  Filiz Topaloğlu Demir; Ayse Serap Karadag
Journal:  Pediatr Dermatol       Date:  2015-02-12       Impact factor: 1.588

Review 8.  [Terbinafine : Drug-induced lupus erythematodes and triggering of psoriatic skin lesions].

Authors:  P Mayser
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

9.  Cell-mediated reactivity in dermatophytosis: differences in skin responses to purified trichophytin in tinea pedis and tinea cruris.

Authors:  T Kaaman
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

10.  Toward a Novel Multilocus Phylogenetic Taxonomy for the Dermatophytes.

Authors:  G Sybren de Hoog; Karolina Dukik; Michel Monod; Ann Packeu; Dirk Stubbe; Marijke Hendrickx; Christiane Kupsch; J Benjamin Stielow; Joanna Freeke; Markus Göker; Ali Rezaei-Matehkolaei; Hossein Mirhendi; Yvonne Gräser
Journal:  Mycopathologia       Date:  2016-10-25       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.